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Abstract
We investigated if hemodynamic variability, cerebral blood flow (CBF) regula-
tion, and their interrelationships differ between patients with transient
ischemic attack (TIA) and controls. We recorded blood pressure (BP) and
bilateral middle cerebral artery flow velocity (MCAv) in a cohort of TIA
patients (n = 17), and age-matched controls (n = 15). Spontaneous fluctua-
tions in BP and MCAv were characterized by spectral power analysis, and
CBF regulation was assessed by wavelet phase synchronization analysis in the
very low- (0.02–0.07 Hz), low- (0.07–0.20 Hz), and high-frequency (0.20–
0.40 Hz) ranges. Furthermore, cerebrovascular CO2 reactivity was assessed as
a second metric of CBF regulation by inducing hypercapnia with 8% CO2
inhalation followed by hyperventilation driven hypocapnia. We found that
TIA was associated with higher BP power (group effect, P < 0.05), but not
MCAv power (P = 0.11). CBF regulation (assessed by wavelet phase synchro-
nization and CO2 reactivity) was intact in patients (all P ≥ 0.075) across both
hemispheres (all P ≥ 0.51). Pooled data (controls and affected hemisphere of
patients) showed that BP and MCAv power were positively correlated at all
frequency ranges (R2 = 0.20–0.80, all P < 0.01). Furthermore, LF phase syn-
chronization index was a significant determinant of MCAv power (P < 0.05),
while VLF and HF phase synchronization index, and TIA were not (all
P ≥ 0.50). These results indicate that CBF stability and control is maintained
in TIA patients, but BPV is markedly elevated. BPV attenuation may be an
important therapeutic strategy for enhancing secondary stroke prevention in
patients who suffer a TIA.
Introduction
Transient ischemic attack (TIA) is a common medical
emergency that frequently heralds a subsequent stroke
(Coull et al. 2004). United States estimates of TIA preva-
lence are as high as 4.1% (women, 75–79 years) (Price
et al. 1993), with an incidence of 1.1 per 1000 population
(Edlow et al. 2006). Furthermore, TIA increases stroke
risk to 8% at 1 week and 11.5% at 1 month following an
event (Coull et al. 2004). Therefore, secondary prevention
of acute stroke is an important strategy against the rising
human and economic cost of stroke (Norrving and Kis-
sela 2013).
The active management of hypertension is an impor-
tant secondary prevention strategy, but it is possible that
other markers of cerebral hemodynamic stability such as
blood pressure variability (BPV), cerebral autoregulation
(CA), and cerebrovascular CO2 reactivity may also be
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influential. Like hypertension, aberrant increases in BPV
(Stead et al. 2006; Ko et al. 2010; Endo et al. 2013) and
impairment of CA (Czosnyka et al. 1996; Budohoski et al.
2015) or CO2 reactivity (Grosset et al. 1993) are associ-
ated with secondary complications and poor clinical out-
comes. But the relevance of these changes in TIA remains
unclear because most studies on the neurological conse-
quences of hemodynamic instability have centered on
acute stroke of moderate or greater severity (e.g., Stead
et al. 2006; Endo et al. 2013). Unlike acute stroke, TIAs
are transient events whereby the focus of clinical manage-
ment is around secondary prevention. To the best of our
knowledge, there are no detailed hemodynamic studies of
TIA patients who are on established secondary prevention
therapies.
Therefore, the goal of this study was to establish
whether there are differences in hemodynamic status and
cerebrovascular control in TIA patients compared to con-
trols. First, we sought to compare the magnitude of BPV
and cerebral blood flow variability (CFV) to test the
hypothesis that TIA patients have increased hemodynamic
variability despite the use of current secondary prevention
therapies. Second, we examined mechanisms that are key
to maintaining cerebrovascular homeostasis, such as CA
and CO2 reactivity, to test the hypothesis that TIA would
be associated with cerebrovascular impairment. Finally,
we sought to identify the key determinants of CFV. To
achieve these objectives, we employed multivariate cere-
brovascular assessment techniques that account for potent
confounders such as the partial pressure of arterial PCO2
(Latka et al. 2005). To exclude the effects of cerebrovas-
cular reactivity from the ventilatory response to PCO2
(Ainslie and Duffin 2009), we employed a dynamic, rather
than steady state, CO2 reactivity procedure (Peebles et al.
2012).
Methods
Participants
Seventeen male patients (mean age 66.6  11.3 [SD]
years) with a clinical diagnosis of TIA (focal neurological
symptoms lasting <24 h) were recruited from Wellington
Hospital, New Zealand, and studied at between 1 and
2 weeks following hospital presentation. This was done to
ensure that patients had been on optimal therapy for at
least 1 week. Patients receiving supplemental oxygen, with
uncontrolled angina, unstable cardiac condition, signifi-
cant cognitive impairment, or other major medical condi-
tion were excluded. At the time of hospital presentation,
stroke risk was assessed using the ABCD2 score. Addition-
ally, 15 age-matched male volunteers (mean age
68.9  4.9 years), without a history of TIA, stroke, or
other major neurological condition were recruited as con-
trols. All participants provided written informed consent
prior to study participation. Ethical approval was given
by the New Zealand Central Regional Ethics Committee.
Measurements
All measurements were conducted in a thermoneutral labo-
ratory (21–22°C), with the participant in the supine posi-
tion. Measurements comprised: right and left middle
cerebral artery flow velocities (MCAv; 2-MHz pulsed Dop-
pler ultrasound, ST3 Digital Transcranial Doppler System,
Spencer Technologies, Seattle), blood pressure (BP;
Finometer MIDI, MLE1054-V, Finapres Medical Systems
B.V., Amsterdam, Netherlands), nasal partial pressure of
end-tidal CO2 (PETCO2), and O2 (Gas analyzer ML206,
ADInstruments, Colorado Springs) and 3-lead electrocar-
diogram. All data were acquired continuously at 1 kHz
(PowerLab/16SP ML795, ADInstruments) and subse-
quently analyzed using custom software (LabVIEW 2013,
National Instruments Corporation, Austin and Matlab
Version R2014a, MathWorks, Natick). Data were excluded
from analyses if there were major signal artifacts or the par-
ticipant was unable to complete the test procedure.
Protocol
An initial 5-min baseline recording was made for all par-
ticipants resting in the supine position. Participants then
underwent dynamic CO2 reactivity testing as previously
described. (Peebles et al. 2012). Briefly, participants first
inhaled 8% CO2 gas followed directly by hyperventilation
to, respectively, raise then lower PETCO2 by approxi-
mately 5 mmHg. In total, this procedure lasted ~3.5 min.
Brachial systolic and diastolic blood pressure (SBP and
DBP, respectively) measurements were made using an
automated blood pressure monitor (Pulsecor, Uscom,
Sydney, Australia).
Cerebral hemodynamic assessment
BPV and CFV were characterized as the spectral powers
of BP and MCAv, respectively. Raw 1 kHz waveforms
were decimated to 1 Hz and passed through a Hanning
window before undergoing fast Fourier transform analysis
based on the Welch algorithm (50% overlap) in the very
low- (VLF, 0.02–0.07 Hz), low- (LF, 0.07–0.20 Hz), and
high-frequency (HF, 0.20–0.40 Hz) ranges. These bands
are commonly defined, and are based on the high-pass fil-
ter characteristics of CA (Zhang et al. 1998).
We performed multivariate wavelet phase synchroniza-
tion analysis to quantify the extent to which BP
and MCAv fluctuations were phase synchronized after
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correcting for CO2-mediated phase distortions (Latka
et al. 2005; Peng et al. 2010). Phase synchronization index
(PSI) values lie between 0 and 1, where 0 represents a
uniform distribution of phase difference and 1 is com-
plete phase synchronization termed “phase lock”. Higher
synchronization between BP and MCAv reflects a pres-
sure-passive circulation and is indicative of worse CBF
regulation. To facilitate comparison to an established
method for CA quantification, we also analyzed data
using linear transfer function analysis as previously
described (Zhang et al. 1998). Transfer function analysis
yields three interpretable parameters reflecting the linear-
ity (coherence), magnitude (gain), and timing (phase)
relationships between BP and MCAv as a function of fre-
quency. To account for interindividual variations in the
middle cerebral artery diameter, MCAv spectral power
and gain were expressed in normalized units, defined as
the signal divided by its mean. MCAv was also normal-
ized in the same manner for CO2 reactivity analysis. A
common interpretation of transfer function metrics is
that higher values of coherence and gain and lower values
of phase are indicative of impaired CA (Zhang et al.
1998). See appendix for further details.
CO2 reactivity was quantified as the linear relationship
between breath-to-breath PETCO2 and average normalized
MCAv within successive breaths, after accounting for BP
as a known covariate using linear mixed-effects models as
previously described (Peebles et al. 2012). First, to ensure
that reactivity estimates accounted for inherent delays in
the breathing circuit, the PETCO2 trace was left shifted
relative to both the BP and MCAv signal. Next, to
account for the physiological latency of the CO2 reactivity
response, the time interval corresponding to the maxi-
mum positive cross correlation between PETCO2 and
MCAv was identified, and time shifted to incorporate the
delay. Finally, CO2 reactivity was assessed using linear
mixed-effects models by entering MCAv as the dependent
variable, and PETCO2 and BP as independent variables.
Analyses were conducted separately for the hypercapnic
and hypocapnic regions of the PETCO2 trace to account
for possible differences in vasodilator versus vasoconstric-
tor responses (Peebles et al. 2012). In contrast to least
square regression, mixed-effects models explicitly account
for the fact that repeated PETCO2 and MCAv measure-
ments made within subjects are correlated in nature and
therefore violate the case independence assumption
required for least squares regression (Lazic 2010). More-
over, linear mixed-effects models analyze data in a single
step, rather than reducing an individual’s data to a sum-
mary measure, before secondary analysis. Thus, the
approach increases the precision of the final estimate by
accounting for the standard error of individual slope esti-
mates (Lazic 2010).
Statistical analysis
Linear mixed-effects models were used to determine
whether hemodynamic, ventilatory, and cerebrovascular
parameters differed between patients and controls. For all
comparisons, data from the right and left MCAv were
averaged for control subjects, but considered separately in
patients to identify potential differences between the
affected and unaffected hemispheres. Pearson’s v2 test was
used to compare the categorical demographic data
between patients and controls. BP and MCAv spectral
powers were log transformed to achieve normal distribu-
tions. To investigate the effect of TIA on hemodynamic
variability, we tested for group (patient vs. control), fre-
quency (VLF, LF, and HF), and group 9 frequency inter-
action effects. To establish if CA was altered by TIA,
group (patients vs. controls) and hemisphere (affected vs.
unaffected) main effects were analyzed. We also tested for
a group 9 PETCO2 interaction effect to establish differ-
ences in CO2 reactivity between patients and controls,
and a hemisphere 9 PETCO2 interaction to establish
differences in CO2 reactivity between the affected and
unaffected cerebral hemispheres. A priori comparisons for
baseline versus hypercapnia and hypocapnia PETCO2
and MCAv values were conducted using Student’s paired
t-tests. Relationships between BP power, group status (pa-
tient or control), CA integrity, and MCAv power were
analyzed using multiple linear regression. All statistical
analyses were performed using SPSS (IBM SPSS Statistics
22, Armonk). Unless otherwise stated, all data are
expressed as mean  SD, with alpha defined as P ≤ 0.05.
Results
Participant characteristics
Demographic and baseline recording physiological charac-
teristics are summarized in Table 1. Seventeen male
patients were studied at a mean of 9.2  3.5 days from
hospital presentation. ABCD2 score was assessed in 13
TIA patients, mean 3.8  1.5. Body mass index, SBP, and
DBP were higher in patients compared to controls (group
effect, all P < 0.05), while MCAv in the affected hemi-
sphere, heart rate, PETCO2, and cerebrovascular conduc-
tance index (CVCi) were similar between groups (group
effect, all P ≥ 0.080). MCAv (52.5  13.2 vs.
49.8  13.7 cm sec1, hemisphere effect P = 0.58), and
CVCi (0.63  0.21 vs. 0.60  0.24 cm sec1, hemisphere
effect P = 0.72) were also similar between the affected
and unaffected hemispheres.
Baseline blood pressure data were obtained in all par-
ticipants. At baseline, bilateral transcranial Doppler failure
occurred in one patient and unilateral failure (affected
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hemisphere) in one patient. Both of these patients did
not undergo CO2 reactivity testing due to transcranial
Doppler failure and a poor finger plethysmography signal,
respectively. Additionally, during CO2 reactivity testing,
unilateral (unaffected hemisphere) transcranial Doppler
failure occurred in one patient during hypocania. Further,
one patient was unable to complete the hypercapnic por-
tion of CO2 reactivity testing. This is summarized in the
respective tables and figures.
Hemodynamic variability
Figure 1 summarizes the relative magnitudes of hemody-
namic variability in the VLF, LF, and HF frequency
ranges. A significant group effect was seen for BPV, indi-
cating that patients had greater BPV than controls
(P < 0.05) across each of the three frequency ranges (in-
teraction effect, P = 0.64) (97% VLF, 88% LF, and 248%
HF higher in patients compared to controls). However,
CFV was not increased in patients (group effect,
P = 0.11), nor did CFV differ between hemispheres
(hemisphere effect, P = 0.61). No group 9 frequency
(P = 0.82) or hemisphere 9 frequency (P = 0.97) interac-
tion was observed, indicating that the relationship
between CFV and frequency was comparable between
groups and hemispheres (for patients).
Cerebral blood flow regulation
Figure 2 shows wavelet phase synchronization between BP
and MCAv after correcting for the effects of PETCO2 as
an additional input. Analyses indicate that PSI did not
differ significantly between patients and controls across all
frequency bands (group effect, all P ≥ 0.075), nor
between hemispheres (hemisphere effect, all P ≥ 0.75).
Transfer function results are presented in Table 2.
There was a significant group effect for HF phase
(P < 0.05), but not VLF or LF phase, indicating that only
HF phase differed between patients and controls. We did
not find a significant group effect for coherence and nor-
malized gain at all frequency ranges (all P ≥ 0.57). No
significant hemisphere effect was found for any transfer
function metric at all frequency bands (all P ≥ 0.59),
indicating similar transfer function values for both the
affected and unaffected hemispheres of patients.
Table 3 presents PETCO2 and MCAv values obtained
during CO2 reactivity testing. The hypercapnia and
hypocapnia procedures caused increases and decreases in
PETCO2, with consistent changes in MCAv in patients
(both hemispheres) and controls. CO2 reactivity analyses
are summarized in Table 4. Group 9 PETCO2 interaction
effects were not seen for hypercapnic or hypocapnic CO2
reactivity (all P ≥ 0.53), indicating that CO2 reactivity did
Table 1. Demographic and baseline recording physiological characteristics
Study group
P value
Patients
(n = 17, male)
Controls
(n = 15, male) Group
Age, years 66.6  11.3 68.9  4.9 0.47
BMI, kg m2 30.8  5.8 26.8  2.2 0.017*
SBP, mmHg 141.8  22.6 126.5  15.4 0.035*
DBP, mmHg 81.3  10.5 72.7  10.1 0.026*
MCAv, cm sec1 Af 52.5  13.2†
Un 49.8  13.7†
44.8  9.8 0.080
(H 0.58)
Heart rate, beats min1 62.3  15.2 61.6  7.5 0.88
PETCO2, mmHg 34.9  2.8 34.7  4.1 0.86
CVCi, cm sec1 mmHg1 Af 0.63  0.21†
Un 0.60  0.24†
0.57  0.10 0.30
(H 0.72)
Hypertension 11 (64.7) 4 (26.7) 0.031*
Hyperlipidaemia 10 (58.8) 3 (20) 0.026*
Diabetes 4 (23.5) 2 (13.3) 0.46
Antihypertensive treatment 17 (100) 4 (26.7) <0.0001*
Lipid lowering treatment 16 (94.1) 4 (26.7) <0.0001*
Antiplatelet treatment 17 (100) 2 (13.3) <0.0001*
Values are mean  SD or number of participants (%). BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure;
MCAv, middle cerebral artery flow velocity; Af, affected hemisphere; Un, unaffected hemisphere; H, hemisphere; PETCO2, partial pressure of
end-tidal CO2; CVCi, cerebrovascular conductance index.
*P < 0.05.
†n = 15 affected hemisphere and 16 unaffected hemisphere of patients for MCAv and CVCi comparisons.
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not differ between patients and controls. CO2 reactivity
was similar between patient hemispheres across all stages
of CO2 reactivity (interaction effect, all P ≥ 0.51).
To explore for possible determinants of CFV, we per-
formed multiple regression analyses with MCAv power
as a dependent variable, and BP power as an indepen-
dent variable, with cohort status (i.e., patient or con-
trol) or PSI as additional predictors. Analysis of pooled
data (controls and affected hemisphere of patients)
indicated that TIA was not a significant determinant of
A B
Group     P = 0.032* 
Frequency     P < 0.001* 
Group x Frequency    P = 0.64
Group     P = 0.11 
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Figure 1. Comparisons for blood pressure and middle cerebral artery flow velocity spectral powers. (A) Patient versus control comparison for
BP power. (B) Patient (affected and unaffected hemispheres) versus control comparisons for MCAv power. Spectral powers were log-
transformed for statistical analyses, however, for ease of interpretation, they are shown here in raw units on log axes. *P < 0.05 for group and
hemisphere main effect. BP, blood pressure; MCAv, middle cerebral artery flow velocity; VLF, very low-frequency; LF, low-frequency; HF, high-
frequency.
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Figure 2. Wavelet phase synchronization between BP and MCAv, with PETCO2 as an additional input. (A) PSI against corresponding pseudo-
frequencies (representing the result of wavelet scale to frequency conversion). (B) Patient (affected and unaffected hemispheres) versus control
comparisons for mean PSI. BP, blood pressure; MCAv, middle cerebral artery flow velocity; PETCO2, partial pressure of end-tidal CO2; PSI, phase
synchronization index; VLF, very low-frequency; LF, low-frequency; HF, high-frequency.
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CFV at all frequency ranges (all P ≥ 0.63). However, in
the LF range, PSI was predictive of CFV (P < 0.05)
(VLF and HF, P ≥ 0.50). Finally, BP power was a
positive predictor of MCAv power at all frequency
ranges (VLF R2 = 0.20, LF R2 = 0.66, HF R2 = 0.80,
all P < 0.01). The corresponding bivariate linear
correlations between BP and MCAv power are shown
in Figure 3.
Discussion
This study assessed key markers of hemodynamic variabil-
ity and CBF regulation in TIA. Contrary to our expecta-
tions, we found that cerebral perfusion stability is
maintained in patients who have suffered a TIA due to
intact cerebrovascular control. However, consistent with
our hypothesis we found that BPV was higher in patients
Table 2. Summary of spontaneous baseline transfer function analysis variables
Variable
Study group P value
Patients
(n = 15 [Af] and 16 [Un])
Controls
(n = 15) Group Hemisphere
VLF coherence Af 0.52  0.11
Un 0.53  0.12
0.51  0.17 0.91 0.73
LF coherence Af 0.66  0.21
Un 0.71  0.20
0.67  0.15 0.95 0.59
HF coherence Af 0.43  0.19
Un 0.43  0.19
0.47  0.15 0.57 0.99
VLF phase, radians Af 0.69  0.34
Un 0.75  0.47
0.51  0.47 0.26 0.69
LF phase, radians Af 0.47  0.27
Un 0.48  0.22
0.52  0.13 0.86 0.98
HF phase, radians Af 0.0011  0.32
Un 0.045  0.32
0.19  0.13 0.026* 0.75
VLF n-gain, % mmHg1 Af 0.97  0.46
Un 1.01  0.41
0.98  0.38 0.95 0.75
LF n-gain, % mmHg1 Af 1.10  0.37
Un 1.10  0.37
1.10  0.27 0.89 0.88
HF n-gain, % mmHg1 Af 1.24  0.40
Un 1.22  0.39
1.21  0.26 0.85 0.95
Values are mean  SD. VLF, very low-frequency; LF, low-frequency; HF, high-frequency; Af, affected hemisphere; Un, unaffected hemisphere;
n-gain, normalised gain.
*P < 0.05 for main effect for group and hemisphere.
Table 3. Partial pressures of end-tidal CO2 and middle cerebral artery flow velocities during CO2 reactivity
Study group
Patients
(n = 15 [Af] and 14 [Un])*
Controls
(n = 14)
Baseline Hypercapnia Hypocapnia Baseline Hypercapnia Hypocapnia
PETCO2, mmHg 31.7  4.4 37.0  5.1† 26.2  4.0† 30.1  5.1 35.2  5.4† 25.1  4.6†
MCAv, cm sec1 Af 42.8  11.9
Un 40.7  13.2
Af 54.9  17.1†
Un 51.9  16.1†
Af 34.7  6.4†
Un 33.1  7.0†
38.1  9.2 46.1  11.5† 32.0  7.3†
Values are mean  SD. Baseline refers to the 30 sec immediately preceding the hypercapnia procedure. Hypercapnia and hypocapnia refer to
the maximum and minimum PETCO2 respectivley, during CO2 reactivity testing. MCAv data is presented in raw units for ease of interpretation,
but was normalised for CO2 reactivity analysis. Af, affected hemisphere; Un, unaffected hemisphere; PETCO2, partial pressure of end-tidal
CO2; MCAv, middle cerebral artery flow velocity.
*For hypocapnia response. For hypercapnia, n = 14 affected hemisphere and 13 unaffected hemisphere of patients.
†P < 0.01 versus baseline.
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compared to controls. Since elevated BPV is an indepen-
dent risk factor for stroke and poor neurological out-
comes, our findings suggest that BPV is a potential
therapeutic target for enhancing secondary stroke preven-
tion in patients who suffer a TIA.
Hemodynamic stability following TIA
Mounting evidence indicates that in addition to estab-
lished risk factors like hypertension, having a stable
hemodynamic profile is important for brain tissue integ-
rity (Ko et al. 2010). Greater BPV in ischemic stroke is
an independent risk factor for hemorrhagic transforma-
tion (Ko et al. 2010), and in patients with a previous
TIA, elevated visit-to-visit systolic BPV is predictive of
stroke (Rothwell et al. 2010). Consistent with this,
impairment of CBF regulatory processes such as CA and
CO2 reactivity are associated with worse outcomes (Gros-
set et al. 1993; Czosnyka et al. 1996; Budohoski et al.
2015). In this study, we found that patients who had suf-
fered an episode of TIA had higher levels of BP spectral
power across the 0.02–0.4 Hz range, indicating greater
perfusion pressure instability compared to age-matched
controls.
The mechanisms underpinning the elevation in BPV are
likely to be complex and frequency dependent. Very low-
frequency fluctuations are thought to originate from a
combination of myogenic activity and humoral factors
(renin–angiotensin system) (Stauss 2007). In contrast, low-
frequency oscillations primarily reflect baroreflex and vas-
cular sympathetic activity (Zhang et al. 2002; Stauss 2007),
and high-frequency variability are related to mechanical
effect of ventilation (Novak et al. 1993) and cardiac
baroreflex function (Sin et al. 2010). Our observation that
BPV was higher in each of these frequency bands are there-
fore consistent with previous studies showing clear associa-
tions between cardiovascular disease and autonomic
dysfunction (Sykora et al. 2009), including baroreflex
impairment (Creager and Creager 1994) and sympathetic
hyperactivity (Grassi 2010). Another possibility is that BPV
was increased secondary to the higher body mass index
(Piccirillo et al. 1998). Moderate obesity, has been shown
to increase HF systolic BPV, in the presence of normal
average blood pressure (Piccirillo et al. 1998). We also
Table 4. Summary of CO2 reactivity
Study group P value
Patients
(n = 15 [Af] and 14 [Un])*
Controls
(n = 14) Group 9 PETCO2 H 9 PETCO2
Hypercapnia response Af 2.1  0.17
Un 2.1  0.19
1.9  0.20 0.64 0.96
Hypocapnia response Af 2.9  0.22
Un 2.8  0.21
3.1  0.23 0.53 0.51
Values are mean  SE in % mmHg1. Af, affected hemisphere; Un, unaffected hemisphere; PETCO2, partial pressure of end-tidal CO2; H,
hemisphere.
*For hypocapnia response. For hypercapnia, n = 14 affected hemisphere and 13 unaffected hemisphere of patients.
R2 = 0.20 
P < 0.01
R2 = 0.66 
P < 0.0001
R2 = 0.80 
P < 0.0001
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Figure 3. Bivariate linear correlations between BP and MCAv spectral powers. Group data are pooled (affected hemisphere in patients [n = 15]
and controls [n = 15]). Results of multiple regression analysis with additional predictors are reported in text. R2 values are coefficients of
determination. Data has been log-transformed and plotted on linear axes. BP, blood pressure; MCAv, middle cerebral artery flow velocity; VLF,
very low-frequency; LF, low-frequency; HF, high-frequency.
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noted that patients had higher mean systolic and diastolic
blood pressure. Increases in average blood pressure corre-
late with greater BPV (Mancia et al. 1983), and may also
explain the observed difference in BPV between patients
and controls. Although we had hypothesized that BPV may
be contributing to an increased risk of stroke by bringing
perfusion close to thresholds for brain tissue integrity and
function (Heiss and Graf 1994), our data suggest that CFV
is not elevated, and that BPV is not a strong predictor of
CFV. This does not imply that BPV is a not a risk factor,
given there are alternative mechanisms by which BPV may
cause vascular injury. Indeed, BPV may still contribute to
mononuclear leukocyte endothelial adhesion and subse-
quent development of atherosclerosis (Chappell et al.
1998). Since high-risk cardiovascular cohorts commonly
exhibit multiple comorbidities, the extent to which these
blood pressure-related variables independently contribute
to a patient’s overall risk warrants further investigation
(Rothwell et al. 2010).
This study is the first to characterize CFV in TIA
patients, but unlike BPV, we did not observe higher CFV.
This seems to be consistent with our observation that vas-
cular mechanisms that are normally involved in the
dynamic stabilization of CBF appear to be intact in this
patient cohort, in agreement with previous studies that
did not find deficits in either CA (Atkins et al. 2010) or
CO2 reactivity (Thompson 1971). Furthermore, in keep-
ing with this inference we did not observe any differences
in either CA or CO2 reactivity between the affected and
unaffected cerebral hemispheres. However, we did observe
a clear difference in HF transfer function phase between
patients and controls. The precise mechanisms underpin-
ning these differences are unclear, but it has been sug-
gested that HF pressure-flow dynamics may reflect the
impedance properties of the cerebrovasculature (Zhang
et al. 1998; Zhu et al. 2011). If so, we speculate that the
differences in HF phase may be due to differences in the
viscoelastic properties of the cerebrovasculature associated
with hypertension or chronic vascular disease.
Hemodynamic determinants of CFV
To identify the key determinants of CFV, we conducted
multiple regression analyses to quantify the extent to
which BPV explained interindividual differences in CFV
variance. Our analyses showed that the relations between
BPV and CFV were clearly frequency dependent with only
20% of CFV variance explained in the VLF range, but up
to 80% explained in the HF range. Furthermore, we con-
sidered the potential role of cohort status (i.e., presence
or absence of prior TIA) and the integrity of CA as possi-
ble additional determinants, and found that TIA was not
a significant predictor of CFV. In contrast, in the LF
range, CA was a determinant of CFV, indicating our abil-
ity to account for CFV improves with integrated physio-
logical measures of CBF control. In this regard, there is a
documented association between cardiovascular disease
and autonomic dysfunction (Sykora et al. 2009), and
recent data suggest that cerebral sympathetic and cholin-
ergic drive may be important determinants of CFV
(Hamner et al. 2010, 2012; Peebles et al. 2012). However,
defining the precise role of cerebral autonomic modula-
tion in patient cohorts would be challenging since cere-
bral autonomic activity can only be assessed using highly
invasive methodologies such as transcranial plasma nore-
pinephrine spillover (Mitchell et al. 2009) or autonomic
blocking studies (Ogoh et al. 2010).
Methodological considerations
The results of this study should be interpreted in cogni-
sance of several methodological considerations. First, we
employed wavelet phase synchronization analysis to assess
CA as it offers several theoretical advantages. Conven-
tional metrics such as transfer function analysis are inher-
ently linear, and assume that pressure-flow dynamics are
stationary over time; an assumption that in practice, is
likely to be violated (Latka et al. 2005). Moreover, these
approaches typically do not account for the influence of
arterial PCO2 on the pressure-flow relationship (Peng
et al. 2010), which may be considerable at low frequencies
(Mitsis et al. 2004). Such shortcomings may underlie why
convergent validity is poor between traditional metrics,
and dissimilar conclusions may be drawn in response to
common physiological perturbations (Tzeng et al. 2012).
For these reasons, we adopted a nonlinear and nonsta-
tionary approach based on wavelet analysis that also
accounts for the confounding effects of arterial PCO2 on
pressure-flow dynamics.
Second, we assessed patients at approximately between
1 and 2 weeks after their initial presentation. This was
done to ensure that our hemodynamic assessments were
undertaken after the initiation and stabilization of current
secondary prevention therapies.
Finally, transcranial Doppler measures cerebral blood
flow velocity, which is only a valid surrogate of volumet-
ric flow providing the cross-sectional area of the inso-
nated vessel remains constant (Serrador et al. 2000). In
this study, we did not obtain direct MRI measurements
of MCA diameter to verify this assumption. But, recent
high-field MRI studies indicate that the MCA diameter
versus PETCO2 relationship is magnitude dependent.
MCA diameter changes at +9 and 13 mmHg PETCO2
(Coverdale et al. 2014), but not within the 7.5 mmHg
range (Verbree et al. 2014). Based on this evidence, we
perturbed PETCO2 to ~5 mmHg above and below resting
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baseline levels to ensure that our Doppler assumptions
can be reasonably justified against current evidence.
Implications
TIA is a harbinger of stroke and therefore episodes of TIA
offer a crucial opportunity to intervene. Greater BPV is a
potential risk factor for poor outcomes (Parati et al. 2013),
but its relevance in TIA is poorly understood. Here, we
have shown that TIA patients have higher BPV approxi-
mately 1–2 weeks after presentation, suggesting this risk
factor remains a potential therapeutic target. However, the
effects of antihypertensive therapy on BPV remains poorly
understood and current blood pressure treatments proto-
cols are primarily focused on reducing absolute blood pres-
sure. One potential agent that should be considered is
calcium channel blockers, which have been shown to selec-
tively reduce BPV when administered in relatively low
doses (Zhang et al. 2011; Tzeng and Macrae 2013). Since
technologies to noninvasively monitor BPV (e.g., finger
plethysmography, ambulatory blood pressure monitors)
already exist, future studies are needed to assess if this
higher BPV can be effectively targeted to reduce the inci-
dence of poor neurological outcomes following TIA.
Conclusion
Our study shows that patients who have suffered a TIA
have greater BPV. We identified BPV as a key determi-
nant of CFV and suggest that hemodynamic instability
may contribute to the elevation of stroke risk in this clini-
cal cohort. Longitudinal studies are needed to establish
whether the assessment and attenuation of hemodynamic
variability in patients presenting with TIA may be benefi-
cial in preventing progression to stroke.
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Appendix:
Wavelet Phase Synchronization
Analysis
The complex wavelet transform of a signal s(t) can be
found by:
Wsða; t0Þ ¼ 1ﬃﬃ
a
p
Z1
1
sðtÞw t  t0
a
 
dt (1)
with a complex mother wavelet w(t). a is the scale creat-
ing translation and dilation of the mother wavelet, and t0
is the time-index sweeping through the time-series. The
instantaneous phase of the signal s(t) can be readily
extracted from its wavelet transform Ws(a, t0) using:
/ða; t0Þ ¼ i½ log Wsða; t0ÞjWsða; t0Þj
 
(2)
Herein, we employ complex Mortlet wavelet:
wðtÞ ¼ 1ﬃﬃﬃﬃﬃﬃ
pfb
p ej2pfctet2fb (3)
with the centre frequency fc, and the bandwidth parame-
ter fb, both set to 1. The scale a is associated with a
pseudo-frequency by:
fa ¼ fc
adt
(4)
with the sampling period dt, also equal to 1. For single-
input single-output model, the phase difference between
BP-MCAv is:
DUPVða; t0Þ ¼ UPða; t0Þ  UVða; t0Þ (5)
where ΦP and ΦV are wavelet-based instantaneous phases
of BP and MCAv, respectively. The synchronization index
is calculated by:
cðaÞ ¼ 1
N
X
t0
cosðDUPVða; t0ÞÞ
" #2 
þ
X
t0
sinðDUPVða; t0ÞÞ
" #2!
(6)
where N is the number of data points in each time series,
and DΦPV(a, t0) is the instantaneous phase difference
between BP and MCAv time series, given in equation (5).
For two-input single-output (BP-MCAv with CO2)
model, the phase difference will be:
DUcPVða; t0Þ ¼ DUPVða; t0Þ
 tan1 jWCHCVjsinðUPC þWCV WPVÞjWPHPVj þ jWCHCVjcosðUPC þWCV WPVÞ
 
(7)
where ΦPC is wavelet-based phase difference of BP-CO2,
and ΨCV and ΨPV are TFA-based phase differences of
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CO2-MCAv and BP-MCAv, respectively i.e., WCV ¼
\HCVðejwÞ;WPV ¼ \HPVðejwÞ; HCV and HPV are the trans-
fer functions of CO2-MCAv and BP-MCAv, respectively.
WC and WP are the wavelet-coefficients using equation (1)
for CO2 and BP, respectively. In equation (7) the first term
[i.e., DΦPV(a, t0)] represents the wavelet-based phase dif-
ference between BP-MCAv, and the second term is the
identified phase error caused by CO2. DΦPV(a, t0) shows
the corrected phase between BP-MCAv after incorporating
the effects of CO2 in equation (7). The synchronization
index for corrected phase difference (eq. 7) is:
cðaÞ ¼ 1
N
X
t0
cosðDUcPVða; t0ÞÞ
" #2 
þ
X
t0
sinðDUcPVða; t0ÞÞ
" #2!
(8)
Transfer Function Analysis
In this study decimated (1 Hz) waveforms were passed
through a Hanning window before undergoing linear
transfer function analysis using the Welch technique
(50% overlap). The transfer function H (f) between BP
and MCAv signals was calculated as:
H (f) = Sxy (f)/Sxx(f)
where Sxx (f) is the autospectrum of input signal (BP)
and Sxy (f) is the cross-spectrum between the two signals
(BP and MCAv). Transfer function magnitude ∣H(f)∣ and
phase spectrums ∣Ф (f)∣ were obtained from the real and
imaginary parts of the complex transfer function:
∣H(f)∣ = {[HR (f)]
2 + [HI (f)]
2}
Ф (f) = tan1[HI (f)/HR (f)]
The squared coherence function MSC (f) was defined
as:
MSC (f) = ∣Sxy (f)∣
2/[Sxx(f)Syy(f)],
where Syy(f) is the autospectrum of changes in output sig-
nal (MCAv).
The relative amplitude and time relationship between
BP and MCAvmean are reflected as transfer gain and phase
shifts over a specific frequency range. To establish sum-
mary statistics, the coherence, gain and phase measures
were band averaged within the VLF, LF and HF ranges.
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